THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $42,800,000 | -26.7% | 45,128,000 | -21.0% | 0.01% | -28.6% |
Q1 2021 | $58,386,000 | +2.6% | 57,128,000 | -5.0% | 0.01% | -6.7% |
Q4 2020 | $56,891,000 | +6.4% | 60,128,000 | 0.0% | 0.02% | 0.0% |
Q3 2020 | $53,448,000 | -25.9% | 60,128,000 | -18.9% | 0.02% | -42.3% |
Q2 2020 | $72,085,000 | +13.9% | 74,128,000 | +16.0% | 0.03% | -7.1% |
Q1 2020 | $63,270,000 | +0.6% | 63,878,000 | +6.6% | 0.03% | +3.7% |
Q4 2019 | $62,897,000 | +23.4% | 59,938,000 | +9.1% | 0.03% | +12.5% |
Q3 2019 | $50,969,000 | +9.8% | 54,938,000 | +2.8% | 0.02% | +14.3% |
Q2 2019 | $46,427,000 | +62.0% | 53,438,000 | +81.5% | 0.02% | +50.0% |
Q1 2019 | $28,653,000 | +1.6% | 29,438,000 | +7.3% | 0.01% | -6.7% |
Q4 2018 | $28,214,000 | -8.1% | 27,438,000 | +5.9% | 0.02% | +7.1% |
Q3 2018 | $30,698,000 | +20.1% | 25,910,000 | 0.0% | 0.01% | +7.7% |
Q2 2018 | $25,565,000 | +20.2% | 25,910,000 | +23.9% | 0.01% | +8.3% |
Q1 2018 | $21,264,000 | -25.2% | 20,910,000 | -19.3% | 0.01% | -29.4% |
Q4 2017 | $28,415,000 | -27.4% | 25,910,000 | -18.8% | 0.02% | -43.3% |
Q3 2017 | $39,150,000 | +54.4% | 31,910,000 | +70.2% | 0.03% | +42.9% |
Q2 2017 | $25,363,000 | +19.3% | 18,750,000 | +11.9% | 0.02% | +10.5% |
Q1 2017 | $21,257,000 | +47.7% | 16,750,000 | +34.0% | 0.02% | +26.7% |
Q4 2016 | $14,393,000 | – | 12,500,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |